ChartRow logo
CNS
$72.03+5.31%
as of close, Oct 20, 2026
☾ AH $72.03 +5.31%
PeersBENTROWSPYQQQNVDAAAPL
Share this page

CNS financial statements

The full income statement, balance sheet, and cash-flow statement for Cohen & Steers Inc (CNS), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 50.6M2024-09 50.6M2024-12 51.0M2025-03 51.0M2025-06 51.0M2025-09 51.0M2025-12 51.4M2026-03 51.4M2026-06 51.4M+1.7% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue556M+7.5%517M+5.7%490M-13.6%567M-2.9%584M+36.6%
378M+9.8%345M+6.0%325M-7.4%351M+8.5%323M-2.7%
Selling, general & administrative71.2M+18.5%60.1M-9.8%66.7M+21.7%54.8M+14.1%48.0M-14.7%
General & administrative71.2M+18.5%60.1M-9.8%66.7M+21.7%54.8M+14.1%48.0M-14.7%
Operating income178M+2.8%173M+5.1%164M-23.8%216M-17.1%260M+173.9%
Other non-operating income-3.83M-618.6%738K+123.5%-3.13M-316.3%-753K-746.1%-89.0K+90.3%
Gain (loss) on equity securities7.70M-55.2%17.2M+67.0%10.3M+131.9%-32.3M-410.7%10.4M+711.7%
Pre-tax income205M-2.3%210M+16.2%180M-8.5%197M-30.2%282M+201.9%
Income tax—46.7M+7.1%43.6M-7.9%47.4M-15.0%55.8M+206.2%
153M+1.3%151M+17.2%129M-24.6%171M-19.1%211M+176.0%
Net income to non-controlling interest4.18M-63.7%11.5M+52.5%7.56M+135.1%-21.6M-246.1%14.8M+1140.0%
$2.97+0.0%$2.97+14.2%$2.60-25.1%$3.47-19.5%$4.31+174.5%
EPS (basic)$2.99-0.3%$3.00+14.5%$2.62-25.4%$3.51-19.9%$4.38+173.7%
Weighted-avg shares (basic)51.2M+1.5%50.4M+2.2%49.3M+1.1%48.8M+1.0%48.3M+1.1%
Weighted-avg shares (diluted)51.5M+1.2%50.9M+2.8%49.6M+0.5%49.3M+0.4%49.1M+0.9%
Dividends per share$2.48+5.1%$2.36+3.5%$2.28+3.6%$2.20-27.9%$3.05+19.1%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Cash & equivalents145M-20.5%183M-2.4%187M-24.2%247M+34.2%184M+347.2%
Accounts receivable79.8M+7.2%74.4M———
877M+7.9%812M+10.3%737M+9.4%673M+36.7%493M+41.4%
Property, plant & equipment65.1M-5.2%68.6M+3.4%66.3M+657.5%8.76M-2.0%8.94M-13.6%
Operating lease right-of-use97.3M-1.9%99.2M-4.0%103M-24.3%136M+519.9%22.0M-29.5%
Goodwill18.8M+7.3%17.5M-3.5%18.1M+1.9%17.8M-3.5%18.4M-4.2%
243M+2.3%237M-2.6%244M-1.0%246M+66.1%148M+20.1%
Non-current lease liability138M-2.0%141M+0.5%140M+1.2%139M+466.0%24.5M-29.8%
Operating lease liability (total)138M-2.0%141M+0.5%140M+1.2%139M+466.0%24.5M-29.8%
562M+9.8%512M+34.2%381M+12.9%338M+32.3%255M+46.5%
Common stock583K+1.4%575K+3.0%558K+1.3%551K+1.5%543K+1.5%
Additional paid-in capital993M+5.3%943M+15.3%818M+6.4%769M+7.5%716M+6.8%
Retained earnings-106M+18.2%-129M+18.2%-158M+7.7%-171M+26.1%-232M+20.4%
Treasury stock321M+9.7%293M+7.8%272M+8.6%250M+12.0%223M+11.3%
Accumulated other comprehensive income-4.66M+53.5%-10.0M-30.1%-7.71M+28.5%-10.8M-83.2%-5.89M-42.4%
Non-controlling interest
49.1M————
Total equity incl. non-controlling611M+17.2%521M+35.0%386M+13.0%342M+33.9%255M
Total liabilities & equity877M+7.9%812M+10.3%737M+9.4%673M+36.7%493M+41.4%
Common shares issued58.3M+1.4%57.5M+3.1%55.8M+1.3%55.1M+1.4%54.3M+1.5%
Common shares outstanding51.0M+0.9%50.6M+2.9%49.2M-10.7%55.1M+1.4%54.3M+1.5%
Shares outstanding (cover)51.4M+0.8%51.0M+2.9%49.5M+0.9%49.1M+0.9%48.7M+0.9%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-120M-224.6%96.7M-43.8%172M+178.8%61.7M-74.6%243M+172.4%
Depreciation & amortization9.79M+5.4%9.29M+126.3%4.11M-6.3%4.38M+7.1%4.09M-12.0%
Share-based compensation46.0M-12.1%52.3M+17.6%44.5M-9.9%49.4M+22.0%40.5M+37.9%
Deferred income taxes561K+288.9%-297K-155.3%537K+144.8%-1.20M-1252.9%104K-2.8%
Change in receivables5.30M-21.3%6.74M+372.5%1.43M+109.0%-15.8M-196.6%16.4M+76.0%
8.36M+107.0%-120M-4.3%-115M-3917.4%-2.86M-106.0%47.6M+2792.0%
Capital expenditure5.98M-48.7%11.7M-79.6%57.0M+1249.4%4.22M+56.7%2.69M+7.7%
Free cash flow-126M-248.7%85.0M-26.0%115M+100.1%57.5M-76.1%240M+177.1%
Acquisitions0.000.000.000.000.00
Sales/maturities of investments398M+28.6%309M+177.2%112M-23.9%147M+40.5%104M+45.6%
73.8M+306.4%18.2M+115.3%-119M-1426.5%8.97M+106.2%-145M+2.3%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued961K-12.6%1.10M+3.5%1.06M+1.9%1.04M+4.2%1.00M+16.5%
Common stock repurchased28.4M+34.6%21.1M-2.0%21.5M-19.7%26.8M+18.7%22.6M-12.9%
Dividends paid127M+6.5%119M+6.0%112M+4.7%107M-27.2%148M+20.5%
Other financing activities-442K-2846.7%-15.0K+97.5%-603K0.000.00
FX effect on cash1.69M+206.8%-1.58M-157.5%2.76M+162.1%-4.44M-344.4%-999K-173.5%
Net change in cash——-61.9M-191.3%67.8M-53.3%145M+336.1%
Income taxes paid51.7M+9.6%47.2M+3.0%45.8M+172.0%-63.6M-39.2%-45.7M-65.0%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap3.23B-31.5%4.71B+26.5%3.72B+18.3%3.14B-30.2%4.50B+25.7%
P/E21.1×-32.3%31.1×+10.1%28.2×+82.4%15.5×-27.3%21.3×-54.5%
P/S5.8×-36.2%9.1×+21.2%7.5×+43.5%5.2×-32.2%7.7×-8.0%
P/B5.7×-37.6%9.2×-9.4%10.2×+1.9%10.0×-43.5%17.6×-14.2%
P/FCF—55.3×+84.4%30.0×-31.5%43.8×+133.6%18.7×-54.7%
Earnings yield4.7%+47.8%3.2%-9.2%3.5%-45.2%6.5%+37.5%4.7%+119.7%
FCF yield—1.8%-45.8%3.3%+45.9%2.3%-57.2%5.3%+120.5%
Dividend yield4.0%+54.6%2.6%-15.1%3.0%-11.6%3.4%+3.4%3.3%-4.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: CNS’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CNS filings on SEC EDGAR → Not investment advice.